On the other hand, NASH patients lose the positive correlation between IL-6 and IL-10, while assuming a positive correlation between IL-6, IL-12, and TNF, implying that IL-10 could modulate IL-6 activity in control individuals and NAFL patients, but not in NASH group. Here, IL10 is linked to metabolic dysfunction-associated steatohepatitis.